630 related articles for article (PubMed ID: 2359853)
21. Low dose gadobenate dimeglumine for imaging of chronic myocardial infarction in comparison with standard dose gadopentetate dimeglumine.
Bauner KU; Reiser MF; Huber AM
Invest Radiol; 2009 Feb; 44(2):95-104. PubMed ID: 19077911
[TBL] [Abstract][Full Text] [Related]
22. Contrast-enhancing properties of Gd-DTPA at 2.0 Tesla.
Schmiedl U; Moseley MM; Ogan MD; Chew WM; Brasch RC
Radiat Med; 1987; 5(1):1-5. PubMed ID: 3628851
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics in rats, dogs and monkeys of a gadolinium chelate used as a liver-specific contrast agent for magnetic resonance imaging.
Schuhmann-Giampieri G; Frenzel T; Schmitt-Willich H
Arzneimittelforschung; 1993 Aug; 43(8):927-31. PubMed ID: 8216456
[TBL] [Abstract][Full Text] [Related]
24. Hepatocellular MR contrast agents: enhancement characteristics of liver parenchyma and portal vein after administration of gadoxetic acid in comparison to gadobenate dimeglumine.
Feuerlein S; Gupta RT; Boll DT; Merkle EM
Eur J Radiol; 2012 Sep; 81(9):2037-41. PubMed ID: 21719224
[TBL] [Abstract][Full Text] [Related]
25. Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system.
Schuhmann-Giampieri G; Schmitt-Willich H; Press WR; Negishi C; Weinmann HJ; Speck U
Radiology; 1992 Apr; 183(1):59-64. PubMed ID: 1549695
[TBL] [Abstract][Full Text] [Related]
26. Contrast-enhanced MR angiography of the run-off vasculature: intraindividual comparison of gadobenate dimeglumine with gadopentetate dimeglumine.
Knopp MV; Giesel FL; von Tengg-Kobligk H; Radeleff J; Requardt M; Kirchin MA; Hentrich HR
J Magn Reson Imaging; 2003 Jun; 17(6):694-702. PubMed ID: 12766899
[TBL] [Abstract][Full Text] [Related]
27. Influence of human serum albumin on longitudinal and transverse relaxation rates (r1 and r2) of magnetic resonance contrast agents.
Giesel FL; von Tengg-Kobligk H; Wilkinson ID; Siegler P; von der Lieth CW; Frank M; Lodemann KP; Essig M
Invest Radiol; 2006 Mar; 41(3):222-8. PubMed ID: 16481904
[TBL] [Abstract][Full Text] [Related]
28. Intra-individual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine for contrast-enhanced magnetic resonance angiography of the supraaortic vessels at 3 Tesla.
Bueltmann E; Erb G; Kirchin MA; Klose U; Naegele T
Invest Radiol; 2008 Oct; 43(10):695-702. PubMed ID: 18791411
[TBL] [Abstract][Full Text] [Related]
29. MR contrast enhancement of intracranial lesions with Gd-DTPA.
Hesselink JR; Press GA
Radiol Clin North Am; 1988 Jul; 26(4):873-87. PubMed ID: 3289078
[TBL] [Abstract][Full Text] [Related]
30. Hepatobiliary enhancement with Gd-EOB-DTPA: comparison of spin-echo and STIR imaging for detection of experimental liver metastases.
Mühler A; Clément O; Vexler V; Berthezène Y; Rosenau W; Brasch RC
Radiology; 1992 Jul; 184(1):207-13. PubMed ID: 1609081
[TBL] [Abstract][Full Text] [Related]
31. [MR angiography of the coronary arteries: comparison of the blood pool contrast medium Gadomer and Gd-DTPA in pigs].
Schnorr J; Wagner S; Ebert W; Heyer C; Laub G; Kivelitz D; Abramjuk C; Hamm B; Taupitz M
Rofo; 2003 Jun; 175(6):822-9. PubMed ID: 12811696
[TBL] [Abstract][Full Text] [Related]
32. Relaxivity of Gadopentetate Dimeglumine (Magnevist), Gadobutrol (Gadovist), and Gadobenate Dimeglumine (MultiHance) in human blood plasma at 0.2, 1.5, and 3 Tesla.
Pintaske J; Martirosian P; Graf H; Erb G; Lodemann KP; Claussen CD; Schick F
Invest Radiol; 2006 Mar; 41(3):213-21. PubMed ID: 16481903
[TBL] [Abstract][Full Text] [Related]
33. Model-based analysis of Gd-BOPTA-induced MR signal intensity changes in cirrhotic rat livers.
Planchamp C; Gex-Fabry M; Becker CD; Pastor CM
Invest Radiol; 2007 Jul; 42(7):513-21. PubMed ID: 17568274
[TBL] [Abstract][Full Text] [Related]
34. A comparison of two MR hepatobiliary gadolinium chelates: Gd-BOPTA and Gd-EOB-DTPA.
Runge VM
J Comput Assist Tomogr; 1998; 22(4):643-50. PubMed ID: 9676461
[TBL] [Abstract][Full Text] [Related]
35. [Efficacy of gadobenate dimeglumine vs gadopentetate dimeglumine in contrast- enhanced magnetic resonance imaging for diagnosis of solitary brain metastases].
Wang QJ; Wang Y; Xu X; Xiao H; Ma L
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Dec; 31(12):1968-73. PubMed ID: 22200693
[TBL] [Abstract][Full Text] [Related]
36. Conventional and rapid MR imaging of the liver with Gd-DTPA.
Hamm B; Wolf KJ; Felix R
Radiology; 1987 Aug; 164(2):313-20. PubMed ID: 3037590
[TBL] [Abstract][Full Text] [Related]
37. [Magnetic resonance tomography of the oropharynx and oral cavity with Gd-DTPA. An optimized study technic and its diagnostic value].
Vogl T; Dresel S; Steger W; Grevers G; Lissner J
Rofo; 1991 Apr; 154(4):375-82. PubMed ID: 1850152
[TBL] [Abstract][Full Text] [Related]
38. Hepatobiliary-specific MR contrast agents: role in imaging the liver and biliary tree.
Seale MK; Catalano OA; Saini S; Hahn PF; Sahani DV
Radiographics; 2009 Oct; 29(6):1725-48. PubMed ID: 19959518
[TBL] [Abstract][Full Text] [Related]
39. [Oral contrast medium for magnetic resonance tomography of the abdomen. II. Phase I clinical testing of gadolinium-DTPA].
Kornmesser W; Laniado M; Hamm B; Clauss W; Weinmann HJ; Schulz E; Wolf KJ; Felix R
Rofo; 1987 Nov; 147(5):550-6. PubMed ID: 2825293
[TBL] [Abstract][Full Text] [Related]
40. [Renal enhancement and excretion of the hepatobiliary contrast agent Gd-EOB-DTPA].
Zangos S; Hammerstingl R; Mack MG; Straub R; Engelmann K; Eichler K; Balzer T; Vogl TJ
Rofo; 2001 Nov; 173(11):1034-40. PubMed ID: 11704914
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]